Eam Investors, LLC Krystal Biotech, Inc. Transaction History

Eam Investors, LLC

$581 Million
Q3 2024

A detailed history of Eam Investors, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 12,858 shares of KRYS stock, worth $1.99 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

12,858

Previous 26,284 51.08%

Holding current value

$1.99 Million

Previous $4.83 Million 51.55%

% of portfolio

0.4%

Previous 0.87%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$174.7 - $213.66 $2.35 Million - $2.87 Million	-13,426 Reduced 51.08%	12,858 $2.34 Million
Q2 2024 Aug 12, 2024	SELL	$153.12 - $183.64 $23,121 - $27,729	-151 Reduced 0.57%	26,284 $4.83 Million
Q1 2024 May 13, 2024	BUY	$108.01 - $179.35 $2.86 Million - $4.74 Million	26,435 New	26,435 $4.7 Million
Q3 2023 Nov 13, 2023	BUY	$108.51 - $130.22 $40,908 - $49,092	377 Added 2.4%	16,091 $1.87 Million
Q2 2023 Aug 11, 2023	SELL	$78.48 - $130.32 $707,340 - $1.17 Million	-9,013 Reduced 36.45%	15,714 $1.84 Million
Q1 2023 Jul 12, 2023	SELL	$72.39 - $84.27 $4.49 Million - $5.23 Million	-62,008 Reduced 71.49%	24,727 $1.98 Million
Q1 2023 May 12, 2023	BUY	$72.39 - $84.27 $3.87 Million - $4.51 Million	53,490 Added 160.9%	86,735 $6.94 Million
Q4 2022 Feb 14, 2023	SELL	$63.14 - $79.9 $12,249 - $15,500	-194 Reduced 0.58%	33,245 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $182,163 - $231,461	2,809 Added 9.17%	33,439 $2.33 Million
Q2 2022 Aug 12, 2022	SELL	$48.93 - $73.47 $158,924 - $238,630	-3,248 Reduced 9.59%	30,630 $2.01 Million
Q1 2022 May 13, 2022	SELL	$51.99 - $72.11 $51,418 - $71,316	-989 Reduced 2.84%	33,878 $2.25 Million
Q4 2021 Feb 11, 2022	BUY	$39.81 - $88.24 $1.39 Million - $3.08 Million	34,867 New	34,867 $2.44 Million
Q2 2020 Aug 13, 2020	SELL	$37.03 - $60.0 $2.57 Million - $4.17 Million	-69,430 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$35.02 - $65.64 $138,924 - $260,393	3,967 Added 6.06%	69,430 $3 Million
Q4 2019 Feb 11, 2020	SELL	$33.17 - $65.23 $744,699 - $1.46 Million	-22,451 Reduced 25.54%	65,463 $3.63 Million
Q3 2019 Nov 13, 2019	BUY	$34.72 - $51.3 $224,534 - $331,757	6,467 Added 7.94%	87,914 $3.05 Million
Q2 2019 Aug 14, 2019	BUY	$27.2 - $41.2 $1.59 Million - $2.42 Million	58,626 Added 256.89%	81,447 $3.28 Million
Q1 2019 May 13, 2019	SELL	$19.86 - $32.9 $202,651 - $335,711	-10,204 Reduced 30.9%	22,821 $751,000
Q4 2018 Feb 13, 2019	BUY	$15.03 - $25.38 $496,365 - $838,174	33,025 New	33,025 $686,000

Others Institutions Holding KRYS

# of Institutions

306

Shares Held

24.2M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $3.97B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Account

Eam Investors, LLC Krystal Biotech, Inc. Transaction History